Associated Papers
Analyzing aggregation propensities of clinically relevant PTEN mutants: a new culprit in pathogenesis of cancer and other PTENopathies.
Palumbo E et al.
Journal of Biomolecular Structure & Dynamics, 2020
31232187 (PubMed )
Supplement: supplement_1.zip › Supplement_S4_mutants_nochange.xlsx › Mutants_no_change
Structural mutation analysis of PTEN and its genotype-phenotype correlations in endometriosis and cancer.
Smith IN et al.
Proteins, 2016
Genomic Rearrangements of PTEN in Prostate Cancer.
Phin S et al.
Frontiers in Oncology, 2013
A new insight into structural and functional impact of single-nucleotide polymorphisms in PTEN gene.
George Priya Doss C et al.
Cell Biochemistry and Biophysics, 2013
The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors.
Stehr H et al.
Molecular Cancer, 2011
21575214 (PubMed )
Supplement: 1476-4598-10-54-S3.XLS › mutations.txt
In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN.
Andrés-Pons A et al.
Cancer Research, 2007
The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover.
Maehama T et al.
Biochemical Society Transactions, 2004
The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.
Georgescu MM et al.
Proceedings of the National Academy of Sciences of the United States of America, 1999
Select a paper to view details